Home/Filings/4/0001550695-25-000103
4//SEC Filing

Ramchandani Rohit 4

Accession 0001550695-25-000103

CIK 0001550695other

Filed

Oct 20, 8:00 PM ET

Accepted

Oct 21, 12:06 PM ET

Size

26.7 KB

Accession

0001550695-25-000103

Insider Transaction Report

Form 4
Period: 2025-10-21
Ramchandani Rohit
Chief Financial Officer
Transactions
  • Disposition to Issuer

    Restricted Stock Units

    2025-10-21$7.75/sh54,181$419,9030 total
    Exercise: $0.00Common Stock (54,181 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2025-10-21$7.75/sh54,180$419,8950 total
    Exercise: $0.00Common Stock (54,180 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2025-10-21$7.75/sh39,336$304,8540 total
    Exercise: $0.00Common Stock (39,336 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2025-10-21$7.75/sh43,589$337,8150 total
    Exercise: $0.00Common Stock (43,589 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2025-10-21$7.75/sh91,596$709,8690 total
    Exercise: $0.00Common Stock (91,596 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Options

    2025-10-21$7.75/sh10,000$77,5000 total
    Exercise: $1.74Common Stock (10,000 underlying)
  • Disposition to Issuer

    Common Stock, par value $0.0001 per share

    2025-10-21299,1010 total
  • Disposition to Issuer

    Restricted Stock Units

    2025-10-21$7.75/sh23,162$179,5060 total
    Exercise: $0.00Common Stock (23,162 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2025-10-21$7.75/sh48,792$378,1380 total
    Exercise: $0.00Common Stock (48,792 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2025-10-21$7.75/sh91,597$709,8770 total
    Exercise: $0.00Common Stock (91,597 underlying)
Footnotes (6)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated July 31, 2025 (the "Merger Agreement"), by and among Performant Healthcare, Inc. ("Performant" or "Company"), Continental Buyer, Inc., a Delaware corporation ("Continental" or "Parent") and Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Continental ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Performant, with Performant surviving the merger as a wholly-owned subsidiary of Continental (the "Merger").
  • [F2]Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement.
  • [F3]Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration.
  • [F4]All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date.
  • [F5]Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to performance-based vesting conditions, that is outstanding immediately prior to the Effective Time (each, a "Performant PRSU") (i) to the extent not vested, shall be deemed to have satisfied such vesting conditions at 100% of target and shall have any time-based vesting conditions waived and (ii) will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (A) the number of Company Shares underlying such Performant PRSU multiplied by (B) the Merger Consideration.
  • [F6]Effective immediately prior to the Effective Time, each option to purchase Company Shares, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant Stock Option") will automatically be canceled and converted into the right to receive (without interest) an amount in cash (less applicable withholding taxes) equal to the product of (i) the aggregate number of Company Shares underlying such Performant Stock Option multiplied by (ii) the excess, if any, of the Merger Consideration over the per share exercise price of such Performant Stock Option.

Issuer

Performant Healthcare Inc

CIK 0001550695

Entity typeother

Related Parties

1
  • filerCIK 0001976990

Filing Metadata

Form type
4
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 12:06 PM ET
Size
26.7 KB